The Gut-Brain Connection in IBD: What a 2026 Systematic Review Found About Anxiety and Depression

Living with inflammatory bowel disease often involves more than managing physical symptoms. Many people with Crohn's disease, ulcerative colitis, or those who have had surgery that resulted in an ostomy report that their mental health is affected in ways that can be difficult to explain to others or to raise with their care team. The gut and the brain are connected through multiple biological pathways, and IBD is recognised as a condition that can affect mental as well as physical wellbeing (NHS).

A 2026 systematic review published in Frontiers in Microbiology has added a specific layer of detail to this picture. The review examined whether changes to gut bacteria, rather than IBD itself as a general diagnosis, are directly associated with anxiety and depression in IBD patients, and whether treatments that target those bacteria can make a measurable difference.

The Review

Published in June 2026, the study by Zhang T, Wang L, Ren Z and colleagues analysed 10 published studies involving a total of 1,040 IBD patients (Zhang T et al., Frontiers in Microbiology, 2026). The review covered two types of study design: six prospective cohort studies, which followed patients over time to observe how gut bacteria and mental health changed together, and four randomised controlled trials, which tested whether treatments aimed at the gut microbiome could reduce anxiety or depression symptoms.

The central question was whether specific gut microbiota changes, the types and balance of bacteria living in the intestine, were associated with anxiety and depression in IBD patients, and whether that association changed when the microbiota were targeted by treatment.

What the Review Found

Reduced bacterial diversity and a shift toward pro-inflammatory bacteria. Across the cohort studies reviewed, IBD patients who had anxiety or depressive symptoms showed lower alpha-diversity in their gut microbiome compared to those who did not have these mental health symptoms. Alpha-diversity refers to the variety of microbial species present in the gut; lower diversity is generally associated with a less resilient gut ecosystem. Alongside this, bacteria associated with pro-inflammatory activity were more abundant in patients with anxiety and depression (Zhang T et al., Frontiers in Microbiology, 2026).

Depletion of bacteria that support the gut lining. Short-chain fatty acids are compounds produced by certain gut bacteria when they break down dietary fibre. They play a role in maintaining the integrity of the intestinal lining, reducing inflammation, and communicating via nerve pathways between the gut and brain. The review found that bacteria responsible for producing short-chain fatty acids were depleted in IBD patients with anxiety or depression compared to those without (Zhang T et al., Frontiers in Microbiology, 2026).

The link held even during remission. One of the more clinically notable findings in the review was that the association between gut microbiota changes and anxiety or depression did not disappear in patients who were in clinical remission, meaning a period when IBD symptoms were controlled and bowel disease was not actively inflamed. The microbiota pattern associated with mental health difficulties was still present even in remission (Zhang T et al., Frontiers in Microbiology, 2026). This is significant because it suggests that gut bacteria changes may contribute to mental health difficulties in IBD independently of active disease, and not simply as a byproduct of physical flaring.

Microbiota-targeted treatments reduced anxiety and depression scores. Among the four randomised controlled trials included in the review, treatments that targeted the gut microbiome, including probiotic supplementation and faecal microbiota transplantation (FMT), were associated with changes in gut bacterial composition and with reductions in measured anxiety and depression scores in IBD patients. The review authors describe the relationship between gut dysbiosis and mental health symptoms as bidirectional: changes in gut bacteria may contribute to anxiety and depression, and mental health may in turn affect the gut environment (Zhang T et al., Frontiers in Microbiology, 2026).

What the Evidence Means in Practice

A systematic review drawing on 10 studies and just over 1,000 patients is a meaningful step in understanding a complex relationship, but it is not a final answer. The studies varied in their design, the patient populations they examined, and the ways they measured both gut microbiota and mental health outcomes. The review authors acknowledge that further research is needed, particularly to clarify the direction and mechanisms of the relationship more precisely.

That said, the consistency of findings across different study types, the fact that the microbiota-mental health link appeared even during remission, and the signal from randomised trials that microbiota-targeted treatments may help, all add to a growing evidence base. The gut-brain axis in IBD is increasingly recognised not as a theoretical concept but as a clinically relevant factor that deserves attention in patient care.

For people living with IBD or with an ostomy, understanding that mental health difficulties may have biological roots in the gut, not only in the psychological demands of living with a chronic condition, may help in conversations with care teams. It is also a reason why treating IBD itself, maintaining gut health where possible, and accessing mental health support are all part of the same care picture.